Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality
B. W.C. Tse, M. Volpert, E. Ratther, N. Stylianou, M. Nouri, K. McGowan, M. L. Lehman, S. J. McPherson, M. Roshan-Moniri, M. S. Butler, J. Caradec, C. Y. Gregory-Evans, J. McGovern, R. Das, M. Takhar, N. Erho, M. Alshalafa, E. Davicioni, E. M. Schaeffer, R. B. JenkinsA. E. Ross, R. J. Karnes, R. B. Den, L. Fazli, P. A. Gregory, M. E. Gleave, E. D. Williams, P. S. Rennie, R. Buttyan, J. H. Gunter, L. A. Selth, P. J. Russell, C. C. Nelson, B. G. Hollier
Research output: Contribution to journal › Article › peer-review
61Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality'. Together they form a unique fingerprint.